Cosmetic Safety Substantiation: What Regulators Expect

Cosmetic regulation is evolving, with regulators placing increasing emphasis on documented safety substantiation rather than informal assessments or supplier assurances. For manufacturers, importers, and brand owners, safety substantiation is now a core compliance requirement that affects market access, inspections, and legal defensibility.

In Canada, cosmetics are regulated under the Food and Drugs Act and the Cosmetic Regulations, which require that products be safe for their intended conditions of use. At the same time, international developments, including the U.S. Modernization of Cosmetics Regulation Act (MoCRA) and EU cosmetic regulations, are raising expectations around how safety is demonstrated and documented.

The direction is clear: cosmetic safety must be evidence-based, traceable, and defensible, and companies must adapt to regulatory changes.

Understanding Cosmetic Safety Substantiation

Cosmetic safety substantiation is the documented scientific rationale demonstrating that a finished product is safe for consumer use. It requires more than confirming that individual ingredients are permitted.

Regulators expect companies to assess the product as a whole, considering factors such as ingredient concentration, intended use, exposure, vulnerable populations, impurities, stability, and manufacturing consistency. Companies must be able to explain why a product is safe and support that conclusion with credible data and professional judgement.

Regulatory Expectations Are Becoming Clearer

While safety has always been required, recent regulatory developments have made safety substantiation more explicit and enforceable.

Health Canada expects manufacturers and importers to maintain documentation supporting the safety of cosmetic products throughout the product lifecycle and to provide it upon request. This expectation extends beyond formulation into manufacturing controls, quality systems, and post-market monitoring.

Internationally, MoCRA reinforces similar requirements by obligating U.S. cosmetic brands to maintain adequate safety substantiation based on generally recognized scientific evidence. For companies operating in multiple markets, this convergence highlights the value of a robust, unified substantiation approach.

Gaps That Create Compliance Risk

Many cosmetic brands underestimate what constitutes adequate safety substantiation. Common issues include:

• Relying solely on raw material safety data
• Failing to reassess safety after formulation changes 
• Lacking documented professional judgement linking data to safety conclusions.

When inspections, complaints, or legal challenges arise, these gaps often become broader quality and governance concerns rather than isolated regulatory issues.

Safety Substantiation as Risk Management

Strong safety substantiation supports more than regulatory compliance. It is a key risk-mitigation and product defence tool.

When adverse reactions or legal claims occur, well-documented safety assessments demonstrate that reasonable, science-based steps were taken to identify and manage risk. As oversight becomes more data-driven, safety substantiation increasingly intersects with quality systems, supplier qualification, and change control.

A defensible safety substantiation program typically includes a structured review of ingredient safety and exposure, assessment of formulation interactions, consideration of stability and contamination risks, and clear documentation of assumptions and conclusions.

Importantly, safety substantiation should be treated as a living document, updated as formulations change, new data emerges, or regulatory expectations evolve.

How MCS Associates Helps Cosmetics Companies

At MCS Associates, we support cosmetic and personal care companies in developing safety substantiation strategies that are scientifically rigorous and regulator-ready. We assist clients with formulation and ingredient reviews, identification of data gaps, integration of safety assessments into quality systems, and preparation of documentation suitable for regulatory review, inspections, or legal proceedings.

By aligning safety substantiation with regulatory strategy and quality management, we help clients move beyond minimal compliance toward long-term risk resilience.

Safety Substantiation Is Becoming the Standard

Cosmetic safety substantiation is no longer a background exercise. It is an increasingly visible indicator of product responsibility and corporate accountability.

Brands that invest in clear, science-based safety documentation are better positioned to respond to regulatory scrutiny, adapt to global change, and protect both consumers and brand reputation. At MCS Associates, we help ensure that safety conclusions are not only scientifically sound but also defensible when it matters most.

Talk to our team about cosmetic safety substantiation and how you can manage your risk levels with best practices. 

Resources:

• Health Canada. Cosmetics and Personal Care Products – Safety Requirements. Government of Canada.
  https://www.canada.ca/en/health-canada/services/consumer-product-safety/cosmetics.html
• Health Canada. Cosmetic Ingredient Hotlist.
  https://www.canada.ca/en/health-canada/services/consumer-product-safety/cosmetics/ingredient-hotlist.html 
• U.S. Food and Drug Administration. Modernization of Cosmetics Regulation Act (MoCRA).
  https://www.fda.gov/cosmetics/cosmetics-laws-regulations/modernization-cosmetics-regulation-act-2022]
• European Commission. Cosmetic Products Regulation (EC) No 1223/2009.